


Package Leaflet: Information for the User
Stimufend 6 mg solution for injection in pre-filled syringe
pegfilgrastim
This medicinal product is subject to additional monitoring, which will allow for the quick identification of new safety information. You can help by reporting any side effects you may get. The last section of the leaflet contains information on how to report side effects.
Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.
Contents of the pack:
Stimufend contains the active substance pegfilgrastim. Pegfilgrastim is a protein produced by biotechnology in the bacterium E. coli. Pegfilgrastim belongs to a group of proteins called cytokines and is very similar to a natural protein (granulocyte-colony stimulating factor) produced by the body.
Stimufend is used to reduce the duration of neutropenia (low white blood cell count) and the incidence of febrile neutropenia (low white blood cell count and fever) that can occur as a result of cytotoxic chemotherapy (medicines that destroy rapidly dividing cells). White blood cells are important cells that help fight infections. These cells are sensitive to the effects of chemotherapy, which can cause their numbers to decrease. If the number of white blood cells becomes too low, there may not be enough to fight off bacteria, which can lead to an increased risk of infection.
Your doctor has prescribed Stimufend to stimulate your bone marrow (the part of the bone where blood cells are produced) to produce more white blood cells to help fight infections.
Do not use Stimufend
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before starting Stimufend:
These may be symptoms of a rare condition called "Capillary Leak Syndrome" and may cause blood to leak from small blood vessels into other parts of the body. See section 4.
Your doctor will regularly perform blood and urine tests as Stimufend may damage the small filters inside the kidneys (glomerulonephritis).
With the use of pegfilgrastim, severe skin reactions (Stevens-Johnson syndrome) have been reported. Stop using pegfilgrastim and seek medical attention immediately if you notice any of the symptoms described in section 4.
You should discuss with your doctor the risk of developing blood cancer. If you develop or may develop blood cancer, you should not use Stimufend, unless your doctor advises you to.
Loss of response to pegfilgrastim
If you experience a loss of response or if the response to treatment with pegfilgrastim cannot be maintained, your doctor will investigate the causes, including whether you have developed antibodies that may neutralize the activity of pegfilgrastim.
Other medicines and Stimufend
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Pregnancy and breastfeeding
Ask your doctor or pharmacist for advice before taking any medicine. Stimufend has not been used in pregnant women. It is important that you inform your doctor if:
If you become pregnant during treatment with Stimufend, inform your doctor.
Unless your doctor advises you otherwise, you should stop breastfeeding if you use Stimufend.
Driving and using machines
Stimufend has no or negligible influence on the ability to drive and use machines.
Stimufend contains sorbitol (E420) and sodium acetate
This medicine contains 30 mg of sorbitol in each 6 mg dose, equivalent to 50 mg/ml. This medicine contains less than 1 mmol of sodium (23 mg) per 6 mg dose; this is essentially "sodium-free".
Stimufend is indicated in patients over 18 years of age.
Follow exactly the instructions for administration of this medicine given by your doctor.
Ask your doctor or pharmacist if you have any questions. The recommended dose is a single subcutaneous injection of 6 mg (under the skin), using a pre-filled syringe, and should be administered at the end of each chemotherapy cycle, at least 24 hours after the last dose of chemotherapy.
Self-injection of Stimufend
Your doctor may consider it more convenient for you to inject Stimufend yourself. Your doctor or nurse will teach you how to do it. Do not attempt to do it unless you have been taught.
For further instructions on how to self-inject Stimufend, read section 6 at the end of this leaflet.
Do not shake Stimufend vigorously as this may affect its activity.
If you use more Stimufend than you should
If you use more Stimufend than you should, inform your doctor, pharmacist, or nurse.
If you forget to use Stimufend
If you are self-injecting and have forgotten to administer your dose of Stimufend, contact your doctor to decide when you should inject the next dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Inform your doctor immediately if you experience any of the following side effects:
These may be symptoms of a rare condition called "Capillary Leak Syndrome" and may cause blood to leak from small blood vessels into other parts of the body and may require urgent medical attention.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label of the pre-filled syringe after EXP. The expiry date is the last day of the month shown.
Store in a refrigerator (2°C - 8°C).
Stimufend may be exposed to room temperature (up to 30°C) for a maximum of 72 hours. If Stimufend has been exposed to room temperature for more than 72 hours, it should be discarded. For questions related to storage, consult your doctor, nurse, or pharmacist.
Do not freeze.
Keep the pre-filled syringe in the outer carton to protect it from light.
Do not use this medicine if you notice that the solution is not entirely clear or contains particles.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Stimufend
Appearance of Stimufend and pack contents
Stimufend is a clear, colorless injectable solution in a pre-filled syringe (6 mg/0.6 ml).
Each pack contains 1 pre-filled glass syringe with a stainless steel needle and a needle cap.
The pre-filled syringe is supplied with an automatic needle guard.
Marketing authorisation holder
Fresenius Kabi Deutschland GmbH
Else-Kroener Strasse 1
61352 Bad Homburg v.d.Hoehe
Germany
Manufacturer
Fresenius Kabi Austria GmbH
Hafnerstrasse 36
8055 Graz
Austria
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website http://www.ema.europa.eu/.
Instructions for use of Stimufend (pegfilgrastim)
Single-dose pre-filled syringe for subcutaneous injection
Important:
Read the leaflet to understand the important information you need to know before using these instructions for use.
Before using a Stimufend pre-filled syringe, read this important information.
Storage of Stimufend pre-filled syringes:
Using the pre-filled syringe:
Call your healthcare professional if you have any questions.
1.1 Prepare your materials |
Before injection
|
After injection(transparent needle guard locked)
Figure B |
1.1 Prepare your materials | |
| |
|
Figure C |
| |
| |
| |
|
Figure D |
| |
| |
Step 2: Wash your hands | |
2.1 Wash your hands | |
|
Figure E |
Step 3: Check your syringe | |
3.1 Remove the pre-filled syringe from the sealed plastic tray | |
| |
Do notgrab the pre-filled syringe by the plunger or the needle cap. If you do, you could damage the syringe or activate the transparent needle guard. |
Figure F |
3.2 Check your syringe | |
|
Figure G |
|
Figure H |
|
Figure I |
Do notuse the pre-filled syringe if it shows any signs of damage. If it does, discard the syringe in the container for disposing of sharp objects (see step 6) and contact your healthcare professional or pharmacist immediately. | |
3.3 Check the liquid | |
Check the liquid through the transparent window of the label to ensure that the medication is clear, colorless, and free of particles or flakes (Figure J). |
Figure J |
Do notuse the pre-filled syringe if the medication is cloudy or colored or if it has particles or flakes. If it does, discard the syringe in the container for disposing of sharp objects (see step 6) and call your healthcare professional or pharmacist immediately. | |
3.4 Check the label | |
Check the label on the syringe to ensure that: | |
|
Figure K |
Do notuse the pre-filled syringe if:
|
Figure L |
If it does, discard the syringe in the container for disposing of sharp objects (see step 6) and call your healthcare professional or pharmacist immediately. | |
Step 4: Prepare the injection | |
4.1 Choose the injection site (Figure M) | |
You can use:
|
Figure M |
|
Figure N |
Do notinject into an area that is painful (sensitive), bruised, red, hard, scarred, or has stretch marks or tattoos. | |
Do notinject through clothing. | |
4.2 Clean the injection site | |
Clean the skin at the injection site with an alcohol swab (Figure O). Let the skin dry. Do nottouch the injection site again before injecting. |
Figure O |
Step 5: Inject the medicine | |
5.1 Remove the needle cap | |
|
Figure P |
Do nottouch the needle or let it touch any surface after removing the needle cap. | |
5.2 Pinch the skin | |
|
Figure Q |
5.3 Insert the needle | |
|
Figure R |
5.4 Inject | |
|
Figure S |
|
Figure T |
Do notremove the needle from the skin when the plunger reaches the end. | |
5.5 Finish the injection | |
|
Figure U |
Important:Call your healthcare professional or pharmacist immediately if: the full dose is not injected or the transparent needle guard does not activate after a complete injection. Injecting an incorrect amount of medication could affect or delay your treatment. | |
Do notreuse the syringe in case of partial injection. | |
Do notattempt to recap the needle, as it could cause a needlestick injury. | |
|
Figure V |
Do notrub the injection site. | |
Step 6: Dispose of the pre-filled syringe | |
6.1 Placeused pre-filled syringes in a container for disposing of sharp objects immediately after use (Figure W). Do notthrow (discard) pre-filled syringes in household trash. |
Figure W |
| |
| |
Do notthrow the used container for disposing of sharp objects in household trash, unless your community guidelines allow it. | |
Do notrecycle the used container for disposing of sharp objects. |
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for STIMUFEND 6 mg INJECTABLE SOLUTION IN PRE-FILLED SYRINGE – subject to medical assessment and local rules.